Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Abeona Therapeutics reported Q1 2026 financial results with increasing commercial adoption of its gene therapy ZEVASKYN, treating three patients and expanding qualified treatment centers to six. The company licensed novel engineered T-cell technology ABO-701 targeting advanced prostate cancer, aiming to file an IND in H2 2027 while deprioritizing o…
BrainsWay Ltd., a leader in noninvasive neurostimulation treatments, announced robust Q1 2026 financial results with revenue growing 35% to $15.5 million and net income more than doubling to $2.3 million year-over-year. The company shipped a record 117 Deep TMS systems in the quarter, expanded insurer coverage including for a new accelerated protoc…
Palvella Therapeutics, a clinical-stage biopharmaceutical company developing novel therapies for serious, rare skin diseases and vascular malformations, has successfully uplisted its common stock from the Nasdaq Capital Market to the Nasdaq Global Market. This uplisting reflects the company's fulfillment of higher listing standards and aims to boos…
BriaCell Therapeutics announced the inclusion of Penn Medicine’s Abramson Cancer Center as a clinical trial location for its ongoing pivotal Phase 3 study evaluating Bria-IMT, an immunotherapy regimen for advanced breast cancer. This expansion reflects increased interest from leading cancer centers and sustained enrollment momentum, with the trial …
Hengrui Pharma and Kailera Therapeutics announced they will present clinical trial data on ribupatide, a GLP-1/GIP receptor dual agonist for obesity treatment, at the American Diabetes Association 86th Scientific Sessions in June 2026. Hengrui will share Phase 2 oral ribupatide results, while Kailera presents data from its Phase 1 bridging study su…
Altimmune, Inc. disclosed its Q1 2026 financial results highlighting robust cash reserves of approximately $535 million as of April 30, 2026. The company plans to initiate the global PERFORMA Phase 3 trial for pemvidutide targeting metabolic dysfunction-associated steatohepatitis (MASH) in the second half of 2026, with important data readouts from …
Electra Battery Materials Corporation has awarded a C$25 million construction contract to WB Melback Corporation to complete the solvent extraction building at its cobalt sulfate refinery near Toronto. Early construction activities are underway, keeping the project on schedule and budget, with commissioning targeted for next year. The refinery aims…
Rent the Runway, a leader in clothing rental and fashion technology, announced that Co-Founder and CEO Jennifer Hyman will step down, with Teri Bariquit appointed as Interim CEO. The company remains focused on scaling its diversified platform including marketplace, media, and B2B services, reaffirming its 2026 financial guidance amid leadership tra…
PolyPid Ltd. has initiated the NDA submission to the FDA for its lead product candidate D-PLEX100, aimed at preventing surgical site infections in colorectal surgery patients. The company expects to complete the submission imminently and is in late-stage discussions for a US commercial partnership. New Phase 3 data presented support the drug's clin…
Nexxen announced that it has expanded the Nexxen TV Home Screen platform by integrating TCL FFALCON and TiVo Ads' native Smart TV inventory into its programmatic demand-side platform (DSP). This provides advertisers with premium, high-visibility advertising placements on Smart TV home screens across the U.S., Canada, UK, and globally, enhancing acc…
Nexxen International Ltd. delivered record Q1 2026 financial results including strong growth in Contribution ex-TAC, programmatic revenue, and CTV revenue. The company raised its full-year 2026 revenue guidance driven by broad strength across programmatic business lines and accelerated adoption of its Nexxen TV Home Screen. Continued investments in…
Goldman Sachs upgraded Umicore to a buy rating and raised its 12-month price target to €33 from €21, citing materially higher forecasts for the company’s Recycling and Specialty Materials divisions. The brokerage’s revised outlook incorporates reduced hedging coverage that should allow more of spot metal price gains to reach realised earnings, and …
Pakistan’s gross value added rose 3.99% year-on-year in the January-March 2026 quarter, the Bureau of Statistics reported Wednesday. Growth slipped slightly from the 4.05% rate in the prior quarter, with the services sector leading the expansion, industry moderating and agriculture recording a modest acceleration.
Tower Semiconductor announced the signing of customer contracts valued at $1.3 billion for silicon photonics revenue in 2027, accompanied by $290 million in customer prepayments for capacity reservation. The company is expanding its multi-fab capacity to meet the growing demand driven by AI infrastructure and data center bandwidth needs. Tower targ…
Advanced Micro Devices is pricing in rapid AI-driven revenue gains and already shows technical confirmation for another leg higher. Strong Q1 growth in data center and accelerating CPU adoption underpin the thesis, even as valuation is elevated. This is an actionable trade: enter on confirmation, size appropriately, and use a $420 stop to protect a…
Altimmune, Inc. announced that its IMPACT Phase 2b trial analyzing pemvidutide's efficacy and safety in treating metabolic dysfunction-associated steatohepatitis (MASH) will be presented in oral and poster sessions at the EASL Congress 2026. The 48-week results include positive outcomes such as fibrosis regression, improved liver inflammation and f…
Vishay Intertechnology posted Q1 2026 revenues of $839.2M, with a gross margin of 21.0% and GAAP EPS of $0.05. The company saw a strong book-to-bill ratio of 1.34 and backlog of 5.7 months, reflecting increased customer demand. Management reaffirmed growth strategy focusing on capacity expansion and backlog turn acceleration to maintain short lead …
A delegation accompanying the U.S. President on a trip to China will include more than a dozen chief executives and senior corporate leaders from major global companies spanning technology, finance, aerospace, semiconductors, payments and agriculture. The White House has provided a roster of participating executives.
Wolfspeed Inc. stock rose 20% Wednesday morning, marking a seventh consecutive session of gains after thematic research firm Citrini identified the company as its "single-stock highlight" in AI infrastructure. The rise follows a pay-walled Citrini report that highlighted Wolfspeed's post-bankruptcy positioning and capacity posture. The stock has cl…
Shares of companies tied to artificial intelligence infrastructure rose in premarket trading on Wednesday, led by memory chip makers, storage suppliers and optical component manufacturers. The move was propelled by tighter memory supply after labor talks at Samsung broke down and by sentiment tied to Nvidia Chief Executive Jensen Huang joining Pres…
Milestone Pharmaceuticals announced first quarter 2026 financial results highlighting the successful commercial launch of CARDAMYST nasal spray for PSVT, achieving approximately 600 prescriptions and coverage for over 25% of U.S. commercially insured lives via Express Scripts. The company commenced a Phase 3 pivotal trial for etripamil in atrial fi…
J.P. Morgan has downgraded Heineken from overweight to neutral, attributing the move to the absence of an announced new management team and unclear strategic direction. While Heineken beat sales expectations in Q1 2026, driven by Asia-Pacific and Africa Middle East, the bank expects momentum to slow into Q2 amid weak performance in the Americas and…
Alphabet's core businesses are accelerating again—Google Cloud reported 63% growth and AI revenue jumped ~800% YoY—while the company sits on $64.4B of free cash flow and a $4.66T market cap. Technicals show bullish momentum, but elevated RSI and a potential analyst downgrade pose a near-term risk. This trade idea recommends a controlled long with d…
Gilat Satellite Networks Ltd. reported a 20% revenue increase in Q1 2026 to $110.5 million and turned a GAAP operating loss in Q1 2025 into a $4.4 million GAAP operating income this quarter. Adjusted EBITDA doubled to $15.1 million. The company reaffirmed its 2026 guidance with an expected revenue growth of approximately 13% and adjusted EBITDA gro…
Nexentis Technologies, through its subsidiary MitoCareX Bio, has achieved a significant drug discovery milestone by optimizing a hit molecule targeting mitochondrial SLC25 carrier proteins, which are involved in difficult-to-treat cancers and inflammatory metabolic diseases. The milestone validates the MITOLINE® platform's capability to overcome st…
